MF
HRMY icon

Magnetar Financial’s Harmony Biosciences HRMY Stock Holding History

Magnetar Financial’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,724
Closed -$476K – 1264
2025
Q4 		$476K Buy
12,724
+5,425
+74% +$178K ﹤0.01% 568
2025
Q3 		$201K Buy
+7,299
New +$251K ﹤0.01% 773

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Magnetar Financial's HRMY Position: Q1 2026 in Review

Magnetar Financial sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 12,724 shares — an estimated $476K sold.

Magnetar Financial first reported a position in HRMY in Q3 2025 and held it in 2 quarters. The position peaked at $476K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Magnetar Financial reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 12,724 Harmony Biosciences shares in Q1 2026, an estimated $476K.
  • Magnetar Financial first reported a position in Harmony Biosciences in Q3 2025 and held it in 2 quarters.
  • Magnetar Financial's Harmony Biosciences position peaked at $476K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.